EDRH
RDHL

Edmond de Rothschild Holding’s Redhill Biopharma RDHL Stock Holding History

Edmond de Rothschild Holding’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3
Closed -$21K – 650
2020
Q2 		$21K Sell
3
-18
-86% -$124K ﹤0.01% 548
2020
Q1 		$93K Buy
+21
New +$105K ﹤0.01% 401
2018
Q3 		– Sell
-18
Closed -$156K – 766
2018
Q2 		$156K Sell
18
-2
-10% -$12.7K ﹤0.01% 508
2018
Q1 		$99K Hold
20
– – ﹤0.01% 562
2017
Q4 		$102K Buy
+20
New +$135K ﹤0.01% 575

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Edmond de Rothschild Holding's RDHL Position: Q3 2020 in Review

Edmond de Rothschild Holding sold out of Redhill Biopharma (RDHL) in Q3 2020, closing a stake of 3 shares — an estimated $21K sold.

Edmond de Rothschild Holding first reported a position in RDHL in Q4 2017 and held it in 5 quarters. The position peaked at $156K in Q2 2018. 47 funds tracked by Wall St. Rank hold RDHL as of Q3 2020.

  • Edmond de Rothschild Holding reported no remaining Redhill Biopharma position as of Q3 2020 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 3 Redhill Biopharma shares in Q3 2020, an estimated $21K.
  • Edmond de Rothschild Holding first reported a position in Redhill Biopharma in Q4 2017 and held it in 5 quarters.
  • Edmond de Rothschild Holding's Redhill Biopharma position peaked at $156K in Q2 2018.
  • 47 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2020.

Based on Edmond de Rothschild Holding's 13F filing for Q3 2020, filed 12 Nov 2020.